{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:40:48Z","timestamp":1792082448287,"version":"4.4.0"},"reference-count":43,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003119","type":"journal-article","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:18:21Z","timestamp":1069384701000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Vinpocetine for cognitive impairment and dementia"],"prefix":"10.1002","volume":"2010","author":[{"given":"Szabolcs","family":"Szatm\u00e1ri","sequence":"first","affiliation":[{"name":"University of Medicine and Pharmacy Tg. Mures; Department of Neurology; Ghe Marinescu 38 Targu Mures Romania 540000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Whitehouse","sequence":"additional","affiliation":[{"name":"Center University Hospitals of Cleveland Room 357C, Fairhill Center; Department of Neurology; 122200 Fairhill Road Cleveland Ohio USA 44120"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,1,20]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD003119-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hup.470040205","article-title":"Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome","volume":"4","author":"Blaha","year":"1989","journal-title":"Human Psychopharmacology"},{"key":"10.1002\/14651858.CD003119-BIB0002|cit2","first-page":"580","article-title":"Long-term study concerning tolerance and efficacy of vinpocetine in elderly patients suffering from a mild to moderate organic psychosyndrome","volume-title":"Senile dementias: early detection","author":"Fenzl","year":"1986"},{"issue":"1","key":"10.1002\/14651858.CD003119-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004850-199100610-00005","article-title":"Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes","volume":"6","author":"Hindmarch","year":"1991","journal-title":"International Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003119-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1532-5415.1987.tb04664.x","article-title":"A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction","volume":"35","author":"Balestreri","year":"1987","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD003119-BIB0005|cit5","article-title":"Vinpotropile in the treatment of cerebral vascular diseases","volume":"2","author":"Filimonov\u00a0VA","year":"2007","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"10.1002\/14651858.CD003119-BIB0006|cit6","article-title":"The use of vinpotropile in chronic brain ishemia","volume":"1","author":"Ivanova","year":"2008","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"3","key":"10.1002\/14651858.CD003119-BIB0007|cit7","first-page":"259","article-title":"Auditory P300 event-related potentials and mini mental state examination performance in dementia; effects of Idebenone and Vinpocetine","volume":"46","author":"Kishimoto","year":"1995","journal-title":"Journal of Nara Medical Association"},{"key":"10.1002\/14651858.CD003119-BIB0008|cit8","unstructured":"Kovacs L Comparative studies of cavinton no source"},{"issue":"Suppl 21","key":"10.1002\/14651858.CD003119-BIB0009|cit9","first-page":"52","article-title":"Implication of vinpotropile in the treatment of patients with cerebral stroke","author":"Kuznetsov","year":"2007","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"4","key":"10.1002\/14651858.CD003119-BIB0010|cit10","first-page":"702","article-title":"A double-blind clinical trial of vinpocetine in the treatment of cerebral insufficiency of vascular and degenerative origin","volume":"40","author":"Manconi","year":"1986","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD003119-BIB0011|cit11","first-page":"261","article-title":"Effect of vinpocetin on cerebral hemodynamics, autoregulation and cognitive frustration in senile patients with a chronic brain ischemia","volume":"Supplement 1","author":"Nesterova","year":"2008","journal-title":"Eur J Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003119-BIB0012|cit12","first-page":"201","article-title":"A double-blind placebo controlled evaluation of the efficacy and safety of vinpocetine in the treatment of patients with chronic vascular or degenerative senile cerebral dysfunction","volume":"3","author":"Peruzza","year":"1986","journal-title":"Advances in Therapeutics"},{"key":"10.1002\/14651858.CD003119-BIB0013|cit13","unstructured":"Pitzus F A double-blind parallel group placebo controlled evaluation of the safety and efficacy of Vinpocetine in the treatment of patients with chronic vascular or degenerative senile cerebral dysfunction Unknown"},{"issue":"10","key":"10.1002\/14651858.CD003119-BIB0014|cit14","first-page":"41","article-title":"The use of vinpocetine in the treatment of cognitive impairment in patients with cerebrovascular diseases","volume":"107","author":"Tanashyan","year":"2007","journal-title":"Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova"},{"issue":"6","key":"10.1002\/14651858.CD003119-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1532-5415.1989.tb05682.x","article-title":"The safety and lack of efficacy of vinpocetine in Alzheimer's disease","volume":"37","author":"Thal","year":"1989","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD003119-BIB0016|cit16","first-page":"301","article-title":"Investigation of the effect of vinpocetine on cerebral blood flow and cognitive\u00a0 functions","volume":"60","author":"Valikovics","year":"2007","journal-title":"Ideggyogy Sz."},{"issue":"10a","key":"10.1002\/14651858.CD003119-BIB0017|cit17","first-page":"1980","article-title":"Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF","volume":"26","author":"Vamosi","year":"1976","journal-title":"Arzneimittelforschung"},{"issue":"supplement 1","key":"10.1002\/14651858.CD003119-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/0197-4580(92)90629-C","article-title":"A double blind placebo and piracetam controlled multicenter trial of vinpocetine in dementia of Alzheimer's type and vascular dementia","volume":"13","author":"Wolters","year":"1992","journal-title":"Neurobiology of Aging"},{"issue":"9","key":"10.1002\/14651858.CD003119-BIB0019|cit19","first-page":"76","article-title":"The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency","volume":"107","author":"Zakharov VV. Lokshina AB. Stakhovskaia LV. Timerbaeva","year":"2007","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"10.1002\/14651858.CD003119-BIB0020|cit20","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD003119-BIB0021|cit21","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"1","key":"10.1002\/14651858.CD003119-BIB0022|cit22","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000480","article-title":"Vinpocetine for acute ischaemic stroke","author":"Bereczki","year":"1997","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003119-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0361-9230(00)00354-3","article-title":"Role of sodium channel inhibiton in neuroprotection: effect of vinpocetine","volume":"53","author":"B\u00f6n\u00f6czk","year":"2000","journal-title":"Brain Research Bulletin"},{"key":"10.1002\/14651858.CD003119-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ddr.430140306","article-title":"Possible emeory-enhancing properties of vinpocetine","volume":"14","author":"Coleston","year":"1988","journal-title":"Drug Development and Research"},{"key":"10.1002\/14651858.CD003119-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0091-3057(86)90465-X","article-title":"Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats","volume":"24","author":"DeNoble","year":"1986","journal-title":"Pharmacology and Biochemistry of Behaviour"},{"key":"10.1002\/14651858.CD003119-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0091-3057(87)90552-1","article-title":"Vinpocetine enhances retrieval of a step-through passive avoidance response in rats","volume":"26","author":"DeNoble","year":"1987","journal-title":"Pharmacology and Biochemistry of Behaviour"},{"key":"10.1002\/14651858.CD003119-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0014-2999(90)90386-K","article-title":"Vinpocetine protects against excitotoxic cell death in primary cultures of rat cerebral cortex","volume":"187","author":"Erdo","year":"1990","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD003119-BIB0028|cit28","volume-title":"Manual zum SKT. Formen A-E","author":"Erzigkeit","year":"1986"},{"key":"10.1002\/14651858.CD003119-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state: A practical method for grading cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD003119-BIB0030|cit30","first-page":"218","article-title":"Clinical Global assessment Scale (CGI)","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD003119-BIB0031|cit31","first-page":"425","article-title":"Effect of vinpocetine on red blood cell deformability in stroke patients","volume":"42","author":"Hayakawa","year":"1992","journal-title":"Arzneim-Forsch\/Drug Research"},{"key":"10.1002\/14651858.CD003119-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-2999(91)90762-F","article-title":"Vinpocetine increases the neuroprotective effect of adenosine in vitro","volume":"205","author":"Krieglstein","year":"1991","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD003119-BIB0033|cit33","first-page":"151","article-title":"Effects of vinpocetine on platelet aggregability and erythrocyte deformability","volume":"20","author":"Kuzuya","year":"1982","journal-title":"Geriatric Medicine"},{"key":"10.1002\/14651858.CD003119-BIB0034|cit34","first-page":"637","article-title":"Psychologie des 20 Jahrhunderts","volume-title":"Demenzen","volume":"X, Psychiatrie","author":"Lauter","year":"1980"},{"key":"10.1002\/14651858.CD003119-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"4","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003119-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(94)00755-V","article-title":"Vinpocetine is as potent as phenytoin to block voltage-gated Na channels in rat cortical neurons","volume":"27","author":"Moln\u00e1r","year":"1995","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD003119-BIB0037|cit37","unstructured":"Mulrow CD Oxman AD Cochrane Collaboration Handbook 1997"},{"issue":"S","key":"10.1002\/14651858.CD003119-BIB0038|cit38","first-page":"1","article-title":"Meta-analysis of cavinton","volume":"7","author":"Nagy","year":"1998","journal-title":"Praxis"},{"key":"10.1002\/14651858.CD003119-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0304-3940(94)90652-1","article-title":"Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodens","volume":"172","author":"Rataud","year":"1994","journal-title":"Neuroscience Letters"},{"key":"10.1002\/14651858.CD003119-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS -AIREN International Workshop","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003119-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jon199884197","article-title":"Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study","volume":"8","author":"Szakall","year":"1998","journal-title":"Journal of Neuroimaging"},{"key":"10.1002\/14651858.CD003119-BIB0042|cit42","volume-title":"International Classification of Disease (ICD-10)","author":"World Health Organisation","year":"1992"},{"issue":"1","key":"10.1002\/14651858.CD003119-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003119","article-title":"Vinpocetine for cognitive impairment and dementia","author":"Szatmari","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T07:47:23Z","timestamp":1628149643000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003119"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,1,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003119","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,20]]}}}